<section class="section technology">
    <div class="container">
        <div class="row">
            <div class="col-md-5">
                <p class="font-uppercase color-gradient section-subtitle">
                    impact on weight lose market
                </p>
            </div>
            <div class="col-md-7">
                <h2 class="h3 section-title">
                    Altanine’s technology can dramatically change the 260bn global dollar
                    weight-loss market.
                </h2>
            </div>
        </div>
        <div class="row">
            <div class="col-md-4">
                <div class="technology-card disadventages">
                    <h5>Saxenda (Liraglutide)</h5>
                    <ul>
                        <li>Daily injection</li>
                        <li>Early weight loss treatment</li>
                        <li>Pervasive GI side effects</li>
                        <li>Patients “move on” due to side effects and daily injections.</li>
                    </ul>
                </div>
            </div>
            <div class="col-md-4">
                <div class="technology-card disadventages">
                    <h5>Wegovy (semaglutide)</h5>
                    <ul>
                        <li>Reduce the column width of the each section.</li>
                        <li>Put Liraglutide on second line same as semaglutide.</li>
                        <li>
                            GLP-1 - this needs to resemble the slide, it is our product and needs to
                            stand out.
                        </li>
                    </ul>
                </div>
            </div>
            <div class="col-md-4">
                <div class="technology-card adventages">
                    <h5>GLP-1 Oral Capsules</h5>
                    <ul>
                        <li>
                            Altanine eliminates injections with proprietary oral capsule formulation
                        </li>
                        <li>
                            Represents significant improvement over existing oral versions of GLP-1
                            receptor antagonists
                        </li>
                        <li>
                            Oral capsules offer a cost-effective weight loss drug therapy compared
                            to high price injectables.
                        </li>
                    </ul>
                </div>
            </div>
        </div>
    </div>
</section>
